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Neuropeptide Degradation Produces Functional Inactivation in the 
Crustacean Nervous System 
Melissa J. Coleman,‘la Paul H. Konstant, lsb Barry S. Rothman, and Michael P. Nusbauml 
‘Neurobiology Research Center and Department of Physiology and Biophysics, University of Alabama at Birmingham, 
Birmingham, Alabama 35294-0021 and *Department of Biology, San Francisco State University, San Francisco, California 
94132 
The pentapeptide proctolin (Proct.; Arg-Tyr-Leu-Pro-Thr) is 
a modulatory transmitter found throughout the crustacean 
nervous system. No information is available in this system, 
however, as to how the actions of this peptide are termi- 
nated. To study this issue in the crab Cancer borealis, we 
incubated exogenous proctolin (1 O-5 M) with either the tho- 
racic ganglion (TG) or with conditioned saline (CS) that had 
been preincubated with the TG. We removed aliquots at 
standard time points for analysis by reverse-phase high- 
performance liquid chromatography (HPLC). We found that 
over time the proctolin peak became progresstvely smaller, 
while three novel peaks appeared and increased in size. 
Comigration experiments using HPLC indicated that the ma- 
jor novel peak was Proct. [2-51 (Tyr-Leu-Pro-Thr), while one 
of the two minor peaks was Proct. [3-51 (Leu-Pro-Thr). The 
other minor peak appeared to be Proct. [l-2] (Arg-Tyr), based 
on similar HPLC retention time to synthetic Proct. [l-2]. The 
reduction in the proctolin peak and the increase in the Proct. 
[2-51 peak was prevented by co-incubation of proctolin with 
any one of several aminopeptidase inhibitors (lo-’ M). Proct. 
[l-2] and Proct. [3-51 appeared to result from a diamino- 
peptidase-mediated cleavage of proctolin. We tested wheth- 
er Kterminal cleavage functionally inactivated proctolin by 
coapplying proctolin (10~~ M) and individual aminopeptidase 
inhibitors (1O-5 M) to the isolated stomatogastric ganglion 
(STG). We found that these inhibitors significantly enhanced 
the proctolin excitation of the pyloric rhythm. Furthermore, 
application of synthetic Proct. [2-51 to the STG had no effect 
unless high concentrations (> 1 Om6 M) were used, and neither 
Proct. [l-2] nor Proct. [3-51 (lOma M) influenced the pyloric 
rhythm. Our results indicate that proctolin is enzymatically 
degraded and thereby biologically inactivated in the crab 
nervous system, primarily by extracellularly located ami- 
nopeptidase activity. 
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Considerable information is available regarding the presence, 
synthesis, release, and postsynaptic effects of neuropeptide 
transmitters (White et al., 1985; Polak and Bloom, 1987; Sossin 
et al., 1989; DeLoof and Schoofs, 1990; Marder and Weimann, 
1992). Less is known regarding the postrelease fate of these 
peptides, and how that fate influences synaptic transmission. 
Thus far, it has been shown that intact neuropeptides can diffuse 
relatively long distances from their release sites (Jan and Jan, 
1982; Mayeri et al., 1985) or can be enzymatically cleaved in 
the extracellular space (McKelvy and Blumberg, 1986; Isaac, 
1987, 1988; Turner, 1987; Molineaux et al., 1988; Rose et al., 
1988; Squire et al., 1991). 
In some systems, extracellular cleavage functionally inacti- 
vates the neuropeptide (Turner et al., 1985; Hall and Lloyd, 
1990; Owens et al., 1992). This inactivation limits the duration 
and distance over which the peptide influences its targets 
(Sigvardt et al., 1986). Sometimes, however, enzymatic cleavage 
either activates or enhances the physiological effects of the pep- 
tide (Turner et al., 1985; Thorsett and Wyvratt, 1987; Owens 
et al., 1992). While some information is available regarding how 
neuropeptide inactivation influences peptidergic effects at both 
the cellular (Sigvardt et al., 1986; Owens et al., 1992) and the 
behavioral level (Turner et al., 1985; Sullivan et al., 1988; Hall 
and Lloyd, 1990) little is known about the role played by neu- 
ropeptide inactivation in sculpting peptidergic modulation of 
neural network activity. 
One well-studied model system for neuropeptide actions on 
rhythmically active networks is the crustacean stomatogastric 
nervous system (STNS; Harris-Wanick et al., 1992b; Marder 
and Weimann, 1992; Weimann et al., 1993). One particularly 
well-characterized rhythmic motor pattern in this system is the 
pyloric rhythm, generated by a neural network in the stoma- 
togastric ganglion (STG; Selverston and Moulins, 1987; Harris- 
Warrick et al., 1992a). The pyloric rhythm is influenced by many 
different modulatory transmitters, including at least six different 
neuropeptides (Harris-Warrick et al., 1992b; Marder and Wei- 
mann, 1992). Among the best-characterized neuropeptides in 
the STNS is the pentapeptide proctolin (Proct.; Arg-Tyr-Leu- 
Pro-Thr; Marder et al., 1986), which is also found throughout 
the crustacean CNS (Schwarz et al., 1984; Siwicki and Bishop, 
1986). Exogenously applied proctolin causes a dose-dependent 
excitation of the pyloric rhythm (Marder et al., 1986; Hooper 
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and Marder, 1987; Nusbaum and Marder, 1989a,b; Golowasch 
and Marder, 1992). Within the STNS, proctolin is found in the 
STG neuropil, in several fibers entering the STG, and in somata 
in the neighboring commissural (COGS) and esophageal (OG) 
ganglia. In the crab Cancer borealis there appear to be only three 
solution plus 20 ~1 of HCI. These samples were analyzed with a Vydac 
C,, HPLC analytical column (0.46 x 25 cm, 300 8, pore size) to which 
was fitted a Vydac C,, guard column and a precolumn filter. Samples 
were analyzed with 0. II trifluoroacetic acid (TFA, pH 2; Aldrich) using 
a linear gradient of acetonitrile (CH,CN) of 0.2-39% in 13 min (3%/ 
min), at a flow rate of 1 .O ml/min. Peaks were detected at 206 nm using 
pairs of proctolin-containing neurons that innervate the STG 
iColeman et al., 1992). Th; includes the paired modulatory 
proctolin neuron (MPN; Nusbaum and Marder, 1989a,b) and 
the paired modulatory commissural neuron 1 (MCNl; Christie 
et al., 1993). Both of these neurons excite the pyloric rhythm. 
METHOD MANAGER software. Control injections were made of synthetic 
a Knauer variable wavelength UV detector that was controlled by the 
peptide and peptidase inhibitors to verify retention time and to ap- 
proximate the amount of material producing each peak of interest. 
Detection threshold for proctolin was approximately 2 x lo-l2 mol. 
In corn&ration experiments, material corresponding to peaks of in- 
terest was collected during the linear gradient using a Dynamax FC-2 
fraction collector (Rainin). Purified samples were dried (SpeedVac Con- 
centrator, Savant) and resuspended in HPLC solution A (99.7% H,O, 
0.2% CH,CN, and 0.1% TFA). These samples were analyzed by HPLC 
using the same C,, column and solvents, but under isocratic conditions. 
The isocractic condition for Proct. [2-51 was 18% CH,CN, while for 
Proct. [3-51 it was 14% CH,CN. Each resuspended fraction was halved 
and the following injections were made to examine each peak of interest: 
(1) half of the collected peak alone, (2) an approximately equivalent 
amount of the putative synthetic analog, and (3) a mixture containing 
the other half of the collected peak and an approximately equal amount 
of the synthetic analog. To confirm sample identity and purity, after 
isocratic elution, each peak of interest was analyzed also using the orig- 
inal linear gradient. As a final test of sample purity, the Proct. [2-51 
peak was collected again, dried, and resuspended for HPLC analysis 
under isocratic conditions using a second solvent system with trieth- 
ylamine (TEA, pH 4.5; Pierce, Inc.) rather than TFA as the counter ion. 
With this solvent system, Proct. [2-51 was assayed at 13% CH,HN. 
In this article we examine the fate of exogenously applied 
proctolin in the nervous system of the crab Cancer borealis. We 
have found, in biochemical experiments using the relatively 
large thoracic ganglion (TG), that proctolin is enzymatically 
degraded primarily by an aminopeptidase (AP) inhibitor-sen- 
sitive process. In complementary electrophysiological experi- 
ments, AP inhibitors enhanced the excitatory effects ofproctolin 
on the pyloric rhythm, suggesting that AP activity terminates 
the proctolin effects in the STG. 
Portions of this work were published previously in abstract 
form (Coleman et al., 199 1). 
Materials and Methods 
Animals. Cancer borealis were obtained from Neptune Seafood & Lob- 
ster Co. (Boston, MA). Crabs were maintained in refrigerated (1 O-l 2”C), 
aerated aquaria with filtered, circulating artificial seawater. Data were 
obtained from 72 male crabs weighing between 300 and 800 gm. 
Solutions. C. borealis physiologi&l &line contained (mmol/l&r) NaCl, 
440: KCl. 11: M&l,. 26: CaCl,. 13: Trizma base. 10: and maleic acid. 
5 (pH 7.4-7.5). ?r&ol& and-ihe ‘AP inhibitors amastatin, bestatinl 
epiamastatin, and puromycin were obtained from Sigma Chemical Co 
(St. Louis, MO). The AP inhibitors arphamenine B and actinonin were 
obtained from Peninsula Labs (Belmont, CA). Proct. [2-51 (Tyr-Leu- 
Pro-Thr) and Proct. [3-51 (Leu-Pro-Thr) were provided by Dr. James 
M. Weimann (Department of Biology, Brandeis University), and were 
synthesized using the procedure for peptide synthesis described in Wei- 
mann (1992). Proct. [l-2] (Arg-Tyr) and additional Proct. [3-51 were 
synthesized by Research Genetics, Inc. (Huntsville, AL). All peptides 
and peptidase inhibitors were stored either as frozen or lyophilized 
aliquots of stock solution (1O-2 M or 10m3 M) that were diluted to the 
working concentration in saline immediately before they were used. 
Ganglionic incubations. Because a large source of neural tissue was 
necessary to cleave amounts of proctolin large enough to be detected 
by absorbance at 206 nm, we used the TG in these experiments. After 
each dissection, the sheathed TG was pinned to a Sylgard (Dow Coming)- 
coated petri dish and preincubated for at least 30 min in 3 ml saline. 
Following several rinses, the TG was then incubated with either (1) 
saline, (2) saline plus Proct. or Pro&. [2-51 (Peptide; 1O-5 M), or (3) 
saline plus peptide ( 10m5 M) and peptidase inhibitor ( 1O-4 M). Each TG 
incubation was maintained for at least 2 hr (1 l-l 5“C) and 220 pl aliquots 
were removed at T = 1, 60, and 120 min. At T = 0 min, the aliquot 
contained 2.2 x 10m9 mol of proctolin. Aliquots immediately received 
25 ~1 of HCl (1 .O M) to inactivate enzymatic activity and were then 
analyzed by reverse-phase high-performance liquid chromatography 
(HPLC; see below). 
Conditioned saline incubations. Incubations of TG to generate con- 
ditioned saline (CS) involved a 30-60 min preincubation with saline, 
which was replaced with fresh saline (3 ml) for a subsequent 2 hr in- 
cubation. This CS was then removed and incubated with the same test 
solutions described above for TG incubations. All incubations of CS 
aliquots were performed at 13°C. Each CS aliquot was a 700 ~1 solution 
of CS (560 ~1) and peptide (1 Om4 M, 70 ~1) plus either peptidase inhibitor 
(lo-’ M) or saline (70 ~1). Final concentrations in each aliquot were 1O-5 
M peptide and 10m4 M inhibitor (when present). From each aliquot, 
HPLC samples (220 ~1) were removed at T = 1, 60, and 120 min, and 
immediately inactivated by adding HCl (1 .O M, 25 ~1). 
HPLC. All HPLC analyses were performed using a Rabbit HPX Dual 
Pump Delivery System with a Dynamic Mixer (Rainin) controlled by 
a Macintosh SE computer using Dynamax HPLC METHOD MANAGER (ver- 
sion 1.3, Rainin). Sample volumes (200 ~1) contained 180 ~1 of CS 
HPLC data analysis. All chromatograms were stored for analysis 
using Dynamax METHOD MANAGER software. The peak areas for the four 
peaks of interest-proctolin and the three degradation products-were 
entered into spreadsheets for further analysis using LOTUS l-2-3, and 
then were imported into SIGMAPLOT (version 4.1) for graphic represen- 
tation. In most cases, data were normalized by representing each peak 
of interest as a percentage of the summed peak area of all four peaks. 
However, this analysis was complicated by the fact that three of the 
peptidase inhibitors used for these studies shared retention times with 
one or another of the four peaks of interest. Thus, arphamenine B had 
the same retention time as Proct. [3-51, puromycin the same as Proct. 
[2-51, and epiamastatin the same as proctolin on the TFA linear gra- 
dient. Therefore, some data are also represented as the absolute peak 
area for each peak of interest. All background peaks with the same 
retention time as Proct. and the Proct. fragments were subtracted from 
the peaks of interest before analysis and graphic representation. Back- 
ground peaks were identified as those peaks that were present, with 
invariant size at all time points, in CS alone aliquots. 
Electrophysiology. Electrophysiological experiments were performed 
on the isolated STNS, which includes the COGS, OG, and STG, plus 
their connecting and motor nerves (Fig. 1). The nervous system was 
pinned down in a Sylgard-coated petri dish, and was superfused con- 
tinuously with chilled (10-14”(Z) physiological saline at a rate of 7-12 
ml/min. Impulse activity from the COGS to the STG was blocked by 
applying isotonic sucrose (7.5 x 10-l M) to a Vaseline well surrounding 
each desheathed COG (Fig. 1). The STG was superfused separately from 
the OG and all nerves by surrounding the STG with a Vaseline well 
that held approximately 0.5 ml saline (Fig. 1). Bath volume was ap- 
proximately 10 ml. 
The activity of the pyloric motor pattern produced by the STG was 
monitored continuously by extracellular recordings from identified STG 
motor nerves (Nusbaum and Marder, 1989a). Extracellular recordings 
were made using stainless steel wire electrodes that were pressed into 
the Sylgard alongside individual motor nerves and isolated from the 
bath by Vaseline. 
To examine the effects of coapplication of proctolin and peptidase 
inhibitor to the STG, saline superfusion in the STG compartment was 
stopped, and the saline was first replaced with 500 ~1 of either saline 
alone or peptidase inhibitor ( 1O-5 M) dissolved in saline, and then in- 
cubated for 10 min (incubation 1). Saline alone was then replaced by 
either saline alone or proctolin (lo-* M or lo-’ M) dissolved in saline 
(500 pl) and again incubated for 10 min (incubation 2). Similarly, pep- 
tidase inhibitor saline was replaced by a saline solution (500 ~1) con- 
taining the same peptidase inhibitor ( 1O-5 M) plus proctolin ( 1Om8 M), 
and incubated for 10 min (incubation 2). After the second incubation, 
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saline superfusion was resumed for 45 min. During test incubations, 
the temperature in the STG compartment never increased by more than 
3°C relative to the temperature in the outer compartment or that oc- 
curring during saline superfusion of the STG compartment. 
Electrophysiology data analysis. Data were analyzed during the final 
minute of each application. We characterized how proctolin influenced 
the pyloric motor pattern by monitoring the pyloric cycle frequency and 
the number of spikes per burst in the lateral pyloric (LP) motor neuron. 
Cycle frequency was calculated as the reciprocal of the duration from 
the first spike in a pyloric dilator (PD) neuron burst to the first spike 
in the next PD neuron burst. Each analyzed segment is an average of 
either the cycle frequency or the number of LP spikes per burst over 
10 consecutive cycles. In some experiments (N = 5) proctolin (lo-’ M) 
caused little (~0.1 Hz) or no increase in pyloric cycle frequency. We 
did not include the results from these experiments in our analysis of 
changes in cycle frequency during application of different peptidase 
inhibitors. All data were entered into SIGMAPLOT for graphic represen- 
tation. 
Statistics. All statistical analyses were performed using GBSTAT (ver- 
sion 3.0). Statistical significance was determined by using either Stu- 
dent’s t test or, for three or more test conditions, analysis of variance 
(ANOVA). Tukey’s t test was used for post hoc multiple comparisons 
of ANOVA, with a critical level of a = 0.05. All data are presented as 
mean + standard deviation (SD). Statistical analyses of the data in 
Tables 2-5 were performed by comparing the difference between in- 
cubation 2 and incubation 1 for each experimental condition relative 
to this difference for the control condition (lo-* M or lo-’ M proctolin 
in saline without any inhibitors, as indicated in each table). 
The proctolin data from Tables 2 and 3, and those from Tables 4 
and 5, were obtained from separate experiments. In each case, the proc- 
tolin data were obtained from the same preparations as were the other 
data in the same table. 
Results 
Proctolin degradation 
Incubations of proctolin with the TG, followed by HPLC anal- 
ysis of aliquots of the incubate at 1,60, and 120 min time points, 
revealed that the amount of proctolin present in the incubate 
diminished over the course of 2 hr (N = 4; Fig. 2A). In contrast, 
when the same amount of proctolin was incubated under the 
same conditions with saline alone, the size ofthe HPLC-detected 
proctolin peak remained constant over a 2 hr period (not shown). 
In parallel with the reduction in the size of the proctolin peak 
during TG incubations there appeared three novel HPLC-de- 
tected peaks, called putative proctolin fragments l-3 (PPF- 1, 
PPF-2, PPF-3) which increased in size with incubation time 
(Fig. 2A). Thus, at T = 1 min, nearly all (97%) of the analyzed 
peak area resulted from proctolin. At T = 120 min, only 82% 
of this area was due to the proctolin peak and the remaining 
18% resulted from the PPF peaks. The concomitant decrease 
in the proctolin peak and increase in three novel peaks suggested 
that proctolin was being degraded by the TG and that the novel 
peaks were the resulting proctolin degradation products (see 
below). 
PPF-1, the largest of the three novel HPLC-detected peaks, 
had a retention time on the linear gradient of 13.3 min, and 
thus eluted immediately before the proctolin peak, which had 
a retention time of 13.7 min (Fig. 2). PPF-2 and PPF-3 had 
retention times of 11.9 min and 10.6 min, respectively (Fig. 2). 
Generally, no PPF-2 or PPF-3 was detected in the T = 1 min 
aliquot. In contrast, the T = 1 min aliquot routinely showed a 
small but discernable peak at the PPF- 1 retention time (Fig. 2). 
This peak, however, resulted from background absorbance as 
it was also present in control (CS alone) HPLC injections (Fig. 
2B, top trace). 
We examined the extent to which the proctolin-degrading 
activity was released into the saline. To this end, we produced 
Figure 1. Schematic diagram of the stomatogastric nervous system 
(STNS) of the crab Cancer borealis. The paired commissural ganglia 
(COG) were surrounded by Vaseline wells (heavy lines) and the saline 
inside the wells was replaced with isotonic sucrose (7.5 x 10-l M). The 
stomatogastric ganglion (STG) was surrounded by a separate Vaseline 
well. The STG was superfused separately from the remainder of the 
STNS. Shaded region in each ganglion represents the neuropil. In the 
STG, the neuropil is surround by the neuronal somata. Three lines 
entering the neuropil represent the axons of neurons innervating the 
STG from COGS and OG. dgn, dorsal gastric nerve; dvn, dorsal ven- 
tricular nerve; ion, inferior esophageal nerve; fvn, lateral ventricular 
nerve; mvn, medial ventricular nerve; OG, esophageal ganglion; son, 
superior esophageal nerve; stn, stomatogastric nerve. 
conditioned saline from the TG, after which this CS was in- 
cubated with proctolin (see Materials and Methods; N = 20). 
Similar to its incubation with the TG, the proctolin peak di- 
minished over time with CS incubation and the same three novel 
peaks were the only nonproctolin peaks to change with time 
(Fig. 2B). Surprisingly, the CS was as effective in degrading 
proctolin as was incubating the peptide directly with the TG 
itself (p > 0.05 Table 1). As shown by the aggregate data (N = 
20) in Figure 3, the amount of each PPF produced in CS at 
T = 60 min and 120 min was significantly greater than that 
produced at T = 1 min. At all time points, the size of the PPF- 1 
peak was greater than either of the other two novel peaks. Con- 
comitantly, there was a significant reduction in the proctolin 
peak at these later time points. Thus, the amount of the initial 
proctolin aliquot (1.8 -t 0.15 nmol) remaining at T = 60 min 
was 1.66 f 0.12 nmol, while there was 1.55 + 0.14 nmol re- 
maining at T = 120 min. For these experiments, during the 120 
min incubations, the proctolin degradation rate was approxi- 
mately 0.19 nmol/liter/sec 
The ability of the TG to produce conditioned saline that 
effectively degraded proctolin was not limited to the first 2 hr 
incubation. In three experiments, three successive conditioned 
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B. CS + Proctolin 
A. TG + Proctolin 
T=l min. 
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:-ii 
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Figure 2. Proctolin (1O-5 M) degradation resulting from incubation with the TG (A) and conditioned saline (C’S, B). In each case, HPLC 
chromatograms show proctolin degradation at different time points. With increasing incubation time, the putative proctolin fragment (PPF) peaks 
increased in size. All unlabeled peaks are background peaks that are unrelated to proctolin. Peaks were analyzed at 206 nm. Peak 3, PPF-3 (RY); 
penk 2, PPF-2 (LPT); peak I, PPF-1 (YLPT); peak P., proctolin (RYLPT = Arg-Tyr-Leu-Pro-Thr). 
salines were produced, each one involving a 2 hr incubation 
with the same TG (Fig. 4). In each of these experiments, we 
found that CS 3 was essentially as effective as CS 1 in reducing 
the size of the proctolin peak and increasing the size of the PPF 
peaks on HPLC. 
Idenbjication of proctolin degradation products 
We reasoned, by comparing the above results with those of 
earlier studies of proctolin degradation in insect neural tissue 
(Quistad et al., 1984; Isaac, 1987), that the PPFs were likely to 
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Figure 3. Mean proctolin and PPF peak areas with increasing incu- 
bation time in CS (N = 20). With increasing incubation time, the per- 
centage of the total peak area due to proctolin decreased while it in- 
creased for the PPFs. Note the different scale on the ordinate for the 
PPF peaks and the proctolin peak. Data are plotted as percentage of 
total peak area, with 100% equal to the sum of the peak areas of PPF- 
3, PPF-2, PPF-1, and Proct.; **, p < 0.01 compared to T = 1 min 
(ANOVA), for each peak of interest. Abbreviations are the same as in 
Figure 2. 
be Proct. [2-51 (PPF-1), Proct. [3-51 (PPF-2) and Proct. [l-2] 
(PPF-3). To determine if this was indeed the case, we performed 
HPLC comigration experiments and compared the retention 
times of purified PPF-1 and PPF-2 with synthetic analogs (see 
Materials and Methods). It was difficult to collect and purify 
sufficient PPF-3 for comigrations, so we compared the HPLC 
retention time of PPF-3 and synthetic Proct. [l-2] (see below). 
Purified PPF-1 did indeed corn&rate with synthetic Proct. [2- 
5], both under isocratic conditions (N = 5; Fig. 5A) and with a 
linear gradient (data not shown). Similarly, PPF-2 comigrated 
with synthetic Proct. [3-51 under isocratic conditions (N = 5; 
Fig. 5B). To verify further the identity of PPF-1, we used a 
second solvent system that used TEA in place of TFA as the 
counter-ion (see Materials and Methods). Under these condi- 
tions, PPF-1 again comigrated with Proct [2-51 (not shown; n 
= 3). Recovery of PPF-2 was insufficient for accurate analysis 
with the TEA solvent system. In parallel HPLC injections, using 
the TFA linear gradient, synthetic Proct. [l-2] had the same 
retention time as PPF-3. 
Proct. [l-2] and Proct. [3-51 could have been coproduced by 
a single diaminopeptidase (DAP)-mediated cleavage. Proct. [3- 
5], however, could also have been produced by AP cleavage of 
Proct. [2-51. To study this latter possibility, we incubated syn- 
thetic Proct. [2-51 (7 x 10m9 mol) both with the TG and with 
CS, using the same protocols and HPLC analysis that were used 
for proctolin incubations. Both TG (N = 3; data not shown) and 
CS (N = 4; Fig. 6) degraded Proct. [2-51 and produced Proct. 
[3-51. After 2 hr CS incubations, 94.3 f 2.2% of the total peak 
area was Proct. [2-51 (Fig. 6) as compared with approximately 
88% being due to the proctolin peak (Table 1) after comparable 
16 
2 
0 
The Journal of Neuroscience, October 1994, 14(10) 6266 
90 
80 
70 
60 
50 
40 
30 
20 
10 
. 0 
cs:12 3 
w PPF-3 PPF-1 
@$$j PPF-2 m Proct. 
Figure 4. Proctolin (10m5 M) degradation by sequentially generated 
conditioned salines from the TG, assayed after incubations of 120 min. 
Data are plotted as the percentage of the total peak area of the proctolin 
and PPF peaks. All three conditioned salines were from normal Cancer 
saline. N = 3; p > 0.05 (ANOVA), for comparisons of corresponding 
peaks in all three incubations. 
proctolin incubations. Thus, after these 2 hr incubations, ali- 
quots contained 1.59 f 0.07 nmol of Proct. [2-51, while aliquots 
at T = 0 min contained 1.80 f 0.19 nmol. This resulted in a 
degradation rate of approximately 0.22 nmol/liter/sec, which 
was similar to the proctolin degradation rate (0.19 nmol/liter/ 
set). As shown in Figure 6, there were increasing amounts of 
Proct. [3-51 produced over the course of the 2 hr incubations. 
Thus, Proct. [3-51 could be produced by serial N-terminal cleav- 
age of proctolin. In contrast to the proctolin incubation exper- 
iments, no Proct. [l-2] was produced from the Proct. [2-51 
incubations. 
Aminopeptidase inhibitors diminish proctolin degradation 
Proctolin had been shown to be sensitive to AP activity (Quistad 
et al., 1984; Isaac, 1987) so we tested the ability of six different 
AP inhibitors to prevent proctolin degradation by CS. As shown 
in Figures 7 and 8, each AP inhibitor that we tested was able 
to prevent at least partially the reduction in the size of the 
proctolin peak and/or the appearance of one or more of the 
proctolin fragment peaks. For the inhibitors amastatin, acti- 
Table 1. Proctolin degradation during CS incubation versus TG 
incubation (O/o total peak area at T = 120 min) 
PPF-3 PPF-2 PPF- 1 Proct. 
fRY) \ , ILPT) \ , (YLPT) \ , (RYLPT) 
CS (N = 20) 0.6 k 0.2 1.1 * 0.5 10.2 f  4.2 88.1 + 4.8 
TG(N=4) 0.9 f  0.2 3.5 k 1.4 13.3 + 4.9 84.2 -t 4.2 
p > 0.05, Student’s t test, for comparison of each peak in TG versus CS. 
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Figure 5. Corn&ration of proctolin 
degradation products and their syn- 
thetic analogs: HPLC chromatograms 
under CH,CN isocratic conditions, fol- 
lowing collection from CH,CN linear 
gradient using TFA as the counter-ion 
(see Materials and Methods) for syn- 
thetic Proct. [2-S] and PPF-1 (A), and 
synthetic Proct. [3-51 and PPF-2 (II). 
Al, Half of synthetic Proct. 12-51 frac- 
tion collected from linear gradient. A2, 
Half of PPF-1 fraction collected from 
linear gradient following proctolin in- 
cubation in CS. A3, Combination of 
second half of synthetic Proct. [2-51 and 
second half of PPF-1 from proctolin 
degradation in CS. BI, Half of synthetic 
Proct. [3-51 fraction collected from pre- 
vious TFA linear gradient. B2, Half of 
PPF-2 fraction collected from previous 
TFA linear gradient following proctolin 
incubation in CS. B3, Combination of 
halfof synthetic Proct. [3-51 and PPF-2 
fractions. Arrows indicate peaks of in- 
terest. Unlabeled peaks are solvent front 
and background peak. 
B. Proct.[3-51 
nonin, and bestatin, we quantitatively analyzed the fraction of 
the initial amount of proctolin that was found in the form of 
proctolin, Proct. [2-51, Proct. [3-51, and Proct. [l-2] after 2 hr 
co-incubations of CS with proctolin and each inhibitor (Fig. 
8A). Because of overlap of HPLC retention times with peaks of 
interest, data for the other three inhibitors could only be ana- 
lyzed as peak areas (see Materials and Methods; Fig. 8B). When 
we compared these peaks with those resulting from incubation 
of proctolin without inhibitor, we found that each of these in- 
hibitors significantly decreased the amount of proctolin degra- 
dation (Fig. 8). In terms of the size of either the proctolin peak 
or that of Proct. [2-51, amastatin and actinonin were equally 
effective and were more effective than bestatin. For example, 
after 2 hr incubations, 88% of the total peak area was proctolin 
when no inhibitors were present, while 93% was proctolin when 
bestatin was also present and 98% was proctolin when either 
amastatin or actinonin was present (Fig. 8A). 
Interestingly, the ability of each inhibitor to prevent the ap- 
pearance of Proct. [2-51 did not necessarily correlate with the 
ability of that inhibitor to block the appearance of Proct. [3-51 
and Proct. [l-2]. Thus, relative to CS alone, only actinonin 
significantly reduced the amount of both Proct. [3-51 and Proct. 
[l-2] (Figs. 7, 8). While amastatin also significantly reduced the 
size of the Proct. [3-51 peak, it did not change the size of the 
Proct. [l-2] peak relative to CS alone (Figs. 7, 8). Additionally, 
whereas bestatin and arphamenine had little influence on Proct. 
[3-51, their presence produced a slight increase in the Proct. [l- 
21 peak size (Fig. 8B). Puromycin did not alter the size of either 
the Proct. [3-51 or Proct. [l-2] peaks. 
Like proctolin degradation, the Proct. [2-51 degradation was 
also amastatin sensitive. Thus, after 120 min co-incubations of 
Proct. [2-51 plus amastatin in CS, the Proct. [2-51 peak was 
indistinguishable from that of controls (percentage total peak 
area, 99.1 f 0.2%; N = 4) and only trace amounts (< 1%) of 
Proct. [3-51 were detected. In contrast, approximately 6% of the 
peak area was represented by the Proct. [3-51 peak after 120 
min incubations of Proct. [2-51 with CS alone (Fig. 6). This 
amastatin-sensitive degradation of Proct. [2-51 presumably ac- 
counts for the decrease in the Proct. [3-51 peak that occurred 
from proctolin incubations in CS plus amastatin. No other in- 
hibitor was tested on Proct. [2-51 degradation. 
Proctolin actions are enhanced by aminopeptidase inhibitors 
To test the physiological role of the AP activity identified in 
our biochemical studies, we examined the ability of the AP 
inhibitors used in these biochemical studies to influence the 
modulatory effects of proctolin on the pyloric motor pattern in 
the stomatogastric ganglion. The experimental setup is illus- 
trated in Figure 1 and is described in the Materials and Methods. 
We reasoned that if the AP inhibitors effectively prevented proc- 
tolin degradation, then they should enhance the proctolin-me- 
diated excitation of the pyloric motor pattern in the STG. To 
test this hypothesis, we applied each AP inhibitor (1 O-5 M) with 
proctolin (1 Om8 M). As predicted, many of these inhibitors did 
enhance the proctolin excitation of the pyloric motor pattern 
(Figs. 9, 10; Tables 2, 3: incubation 2 vs 1). In contrast, none 
of these inhibitors influenced the pyloric motor pattern when 
applied alone (Tables 2, 3: incubation 1). The enhanced exci- 
tation that occurred when these inhibitors were coapplied with 
proctolin included (1) a faster pyloric motor pattern, and (2) 
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Figure 6. Proct. [2-S] (lOms M) is degraded uring incubations with 
CS from the TG. The percentage of the total peak area (Proct. [2-51 
plus Proct. [3-51) due to Proct. [2-51 decreased while that due to Proct. 
13-51 increased with increasing incubation time. N = 4: **. D < 0.01: 
i, p 2 0.05; compared to T = lmin (ANOVA) for each peakof interest: 
Data are plotted as in Figure 3. 
more intense impulse bursts in several pyloric neurons. For 
example, in the experiment shown in Figure 9, bestatin only 
slightly enhanced the proctolin-mediated excitation of the py- 
loric rhythm, but amastatin increased this activity such that it 
was equivalent to that occurring in the presence of a IO-fold 
higher concentration of proctolin. Only the peptidase inhibitors 
amastatin and arphamenine B significantly increased the pyloric 
cycle frequency relative to proctolin (1 Om8 M) alone (Table 2). 
While the effects of actinonin on cycle frequency appeared to 
be comparably large, they were only studied in two experiments 
(Table 2). In contrast, all five inhibitors enhanced the number 
of LP neuron impulses per burst as compared with proctolin 
( 1O-8 M) alone (Fig. 10, Table 3). Bestatin and arphamenine B, 
however, were less effective than actinonin, epiamastatin, and 
amastatin, all of which enhanced the effects of lo-* M proctolin 
on LP neuron activity such that it was indistinguishable from 
that resulting from application of lo-’ M proctolin (Fig. 10, 
Table 3). 
Physiological actions of proctolin degradation products 
To test whether the observed proctolin cleavages were inacti- 
vating the peptide, we studied the effects on the pyloric motor 
pattern of bath applying each identified proctolin degradation 
product to the STG. As shown in Figure 11, when we applied 
Proct. [2-51 in the concentration range where the parent peptide 
effectively excites the pyloric rhythm ( 10m9 M to 1O-6 M), there 
was no effect on this motor pattern. However, higher doses of 
Proct. [2-51 (> 10m6 M) did excite the pyloric rhythm (n = 3-5). 
This effect was moderately strong for applications of 1O-5 M 
Proct. [2-51 and it was particularly strong for applications of 5 
x 1O-5 M (Fig. 11). These latter effects were indistinguishable 
from those of lower doses of the parent peptide (lo-’ M proc- 
tolin; Fig. 1, Tables 4, 5). In contrast to the results with Proct. 
0 
CS + Proct. 2 
w/Amast. $ 
./.. . . . _. _.. , 
time (min.) 
19 
Figure 7. Proctolin degradation in the presence of different amino- 
peptidase inhibitors: HPLC chromatograms of aliquots of proctolin 
(1O-5 M) plus or minus aminopeptidase inhibitor (10m4 M) in CS, after 
incubation for 120 min (T = 120 min). The size of the proctolin peak 
and that of peak I were both reduced with aminopeptidase inhibitors 
present when compared with CS plus proctolin alone. Additionally, peak 
2 was reduced by amastatin and actinonin, while peak 3 was reduced 
by actinonin. Best., bestatin; Actin., actinonin; Amast., amastatin; Proct., 
proctolin. 
[2-51, bath application of even higher doses ( 10e4 M) of Proct. 
[l-2] and Proct. [3-51 had no effect on the pyloric rhythm (N 
= 4; data not shown). 
Discussion 
Proctolin degradation by conditioned saline 
In this study we have shown that the pentapeptide proctolin is 
cleaved by the crab nervous system. This cleavage is mediated 
primarily by AP activity, although there appears to be some 
DAP-like activity as well. Surprisingly, we found that saline 
preincubated with the TG had nearly as much proctolin-cleaving 
activity as the TG. Thus, nearly all of the proctolin-cleaving 
activity was probably released into the extracellular space rather 
than remaining tightly bound to ganglionic membranes. 
There are several possible explanations for the generation of 
proctolin-degrading activity in the CS. For example, this activity 
might have resulted from exocytosis. Alternatively, the activity 
might have been tethered to the extracellular surface of gangli- 
onic membranes by a labile linkage that was continually cleaved. 
Neither of these possibilities was examined in our experiments. 
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Figure 8. Summary of effectiveness of different aminopeptidase inhibitors on CS-mediated proctolin degradation. A, Percentage of total peak area 
represented by each of the proctolin-related peaks. Data were collected following proctolin incubation ( 1O-5 M) with CS plus or minus an amino- 
peptidase inhibitor (10m4 M) at T = 120 min. For each condition, data are plotted as the mean peak area for each peak divided by the mean total 
area for the four proctolin-related peaks. B, Mean peak area of proctolin and each proctolin fragment after CS incubation of proctolin (1O-5 M), 
plus or minus an aminopeptidase inhibitor (1O-4 M; T = 120 min). Data for no inhibitors, bestatin, actinonin, and amastatin are replotted from 
A. Missing bars indicate values for which the inhibitor shared the same retention time as the peak of interest. Overlapping peaks are arphamenine 
B and Proct. [3-51, puromycin and Proct. [2-S], and epiamastatin and proctolin. Statistical analysis indicates significantly different than CS with 
no inhibitors within each peak of interest: **, p < 0.01; *, p < 0.05; ANOVA. 
However, there is precedence for the latter possibility in that 
other cell surface enzymes, including acetylcholinesterase, are 
membrane anchored via a phospholipase C-sensitive, glycosyl- 
phosphatidylinositol linkage (Futerman et al., 1985; Haas et al., 
1988; Low and Saltiel, 1988). Such a linkage also exists for at 
least one AP, aminopeptidase P (AP-P, EC 3.4.11.9; Hooper 
and Turner, 1988). 
Multiple proctolin-degrading enzymes? 
Our results are consistent with proctolin cleavage in the crab 
nervous system being mediated by at least two different en- 
zymes. The major proctolin-degrading activity appears to be an 
AP, since most of the proctolin cleavage is suppressed by AP 
inhibitors, and our HPLC comigration experiments indicate that 
the major AP inhibitor-sensitive degradation product is Proct. 
[2-51. 
The second proctolin-degrading activity appears to be a DAP. 
This conclusion is based primarily on the coappearance of Proct. 
[l-2] and Proct. [3-51 in proctolin incubations with either CS 
or TG. While Proct. [3-51 was also produced via serial, AP 
inhibitor-sensitive cleavages of proctolin, the larger source of 
Proct. [3-51 generation appeared to be cleavage of the Tyr-Leu 
bond via DAP activity. This interpretation is supported by the 
observation that in most of the proctolin co-incubations with 
AP inhibitors, the same amounts of Proct [3-51 and Proct. [l- 
21 were generated as without any inhibitor present, even though 
Proct. [2-51 production was reduced significantly. The DAP-like 
activity, however, can only account for about 20% of the total 
proctolin degradation, because approximately 80% of the proc- 
tolin degradation is eliminated in the presence of the AP-in- 
hibitor amastatin. 
Identity of the proctolin-cleaving peptidases 
Previous workers (McDonald and Barrett, 1986; Turner et al., 
1989) have characterized four distinct mammalian APs that 
show some similarity to the proctolin-cleaving activity that we 
have described in the crab nervous system. These include leu- 
tine AP (LAP; EC 3.4.1 l.l), aminopeptidase M (AP-M; EC 
3.4.11.2), aminopeptidase B (AP-B; EC 3.4.11.6), and amino- 
peptidase A (AP-A, EC 3.4.11.7). Each of these peptidases ex- 
hibits different substrate and inhibitor specificities. Of these 
enzymes, the likeliest ones to degrade proctolin effectively are 
LAP, AP-M, and AP-B. Purified mammalian LAP has been 
shown to cleave proctolin effectively in solution, although the 
cleavage products were not identified (Brown, 1977; Davis et 
al., 1989). The preferred substrates for both AP-M and AP-B 
include peptides, such as proctolin, with an N-terminal arginine 
(McDonald and Barrett, 1986; Turner et al., 1989). Each ofthese 
APs, however, has been reported to have an inhibitor-sensitivity 
profile that is distinct from that of the proctolin-sensitive AP 
activity seen by us in the crab (Umezawa and Aoyagi, 1983; 
McDonald and Barrett, 1986). It is, however, possible that the 
AP activity in our study represents several different enzymes 
with overlapping inhibitor sensitivities, rather than a single AP. 
Supporting this possibility is our finding that the crab AP ac- 
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Figure 9. Effects of bath-applied aminopeptidase inhibitors (lo+ M) on the excitatory effects of proctolin (lo-* M) on the pyloric motor pattern. 
Activity of an ongoing pyloric motor pattern from a single experiment is monitored by extracellular ecordings of a pyloric motor nerve, the dvn 
(see Fig. 1). LP, lateral pyloric constrictor motor neuron; PY, pyloric constrictor motor neuron; PD, pyloric dilator motor neuron. 
tivity was approximately equally inhibited by amastatin, acti- 
nonin, puromycin, and epiamastatin. 
Previous work in the insect nervous system showed that ex- 
tracellular proctolin is a substrate of AP activity and that its 
degradation was most effectively inhibited by amastatin (Quis- 
Table 2. The effect of aminopeptidase inhibitors on the proctolin- 
mediated excitation of the pyloric rhythm cycle frequency (Hz) 
Saline 
superfusion Incubation 1 Incubation 2 
Saline (n = 5) 0.45 + 0.2 0.47 + 0.2 0.46 iz 0.2t 
lo-* M proctolin (n = 9) 0.46 f 0.2 0.47 + 0.1 0.54 + 0.2t 
Bestatin (n = 7) 0.39 -t 0.2 0.44 IL 0.2 0.50 z!c 0.2t 
Epiamastatin (n = 5) 0.48 zk 0.1 0.48 + 0.2 0.55 + 0.2t 
Arphamenine B (n = 5) 0.39 * 0.1 0.38 -t 0.2 0.49 z!r 0.2* 
Actinonin (n = 2) 0.54 z!z 0.4 0.63 f  0.4 0.72 Z!I 0.2 
Amastatin (n = 5) 0.47 f  0.1 0.47 + 0.1 0.61 + O.l* 
lo-’ M pro&Olin (n = 5) 0.42 + 0.2 0.45 +- 0.2 0.66 & 0.2* 
“Incubation 1” indicates STG incubation with either saline (for saline, 10-O M 
proctolin, and lo-’ M pructolin) or aminopeptidase inhibitor (10-l M, for all 
others). “Incubation 2” indicates STG incubation with incubate 1 plus either 
saline (for saline), lo-’ M proctolin (for IO-’ M proctolin), or lo+ M proctolin 
(for all others). See Materials and Methods for further details. 
* Value is significantly different from lo-* ki proctolin application: p < 0.05, 
Student’s t test. 
t Value is significantly different from lo-’ M proctolin application: p c 0.05, 
Student’s t test. 
tad et al., 1984; Isaac, 1987). However, other aspects of the 
inhibitor profile determined by Isaac (1987) for the proctolin- 
cleaving AP activity of insect neural membrane fractions dif- 
fered from that of the AP activity described in the present study. 
Proctolin was also degraded by DAP activity in these previous 
studies, although the particular DAP responsible for this deg- 
radation was not identified (Quistad et al., 1984; Isaac, 1987). 
However, Hui (1988) reported that proctolin is readily cleaved 
by DAP V. DAP V, purified from rat brain membranes, strongly 
prefers peptides with an arginine residue at the N-terminus, 
including proctolin. 
Table 3. The effect of aminopeptidase inhibitors on the proctolin- 
mediated excitation of the LP neuron (spikes per burst) 
Saline 
sunerfusion Incubation 1 Incubation 2 
Saline (n = 8) 4.4 + 1.4 
lo-* h3 proctolin (n = 12) 4.2 k 1.5 
Bestatin (n = 8) 5.3 + 2.8 
Arphamenine B (n = 7) 4.2 f  1.6 
Actinonin (n = 4) 5.3 z!z 3.4 
Epiamastatin (n = 5) 4.1 f  1.4 
Amastatin (n = 11) 5.0 f  1.5 
lo-’ M proctolin (n = 8) 4.8 f 1.9 
4.4 f  1.6 4.3 + 1.6*+ 
4.3 + 1.7 6.6 f  2.7t 
5.6 -+ 3.3 9.1 f  3.4*t 
3.6 rt 2.0 8.0 + 2.5*t 
5.6 +- 2.6 11.2 zk 3.2* 
4.0 J- 2.1 9.9 IIZ 3.2* 
5.5 z!I 2.0 11.6 * 2.9* 
4.5 rfi 2.1 12.6 I!I 3.5* 
Details are as for Table 2. 
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Figure 10. Cumulative results of the influence of different aminopep- 
tidase inhibitors on the proctolin-mediated changes in the number of 
LP neuron impulses per burst. Data represent the mean difference from 
application of either saline (saline, 1O-8 M Proct., lo-’ M Proct.) or the 
relevant inhibitor. Each inhibitor (1O-5 M) was first applied alone, and 
then immediately coapplied with proctolin ( 1O-8 M). S, saline (n = 8); 
IO-p M Pr, proctolin (n = 12); B, bestatin (n = 8); Ar, arphamenine (n 
= 8); AC, actinonin (n = 4); E, epiamastatin (n = 5); Am, amastatin (n 
= 10); IO-’ M; Pr, proctolin (n = 8). *, p i 0.05 (relative to lo-* M 
Proct.); +, p < 0.05 (relative to lo-’ M Proct.); Student’s t test. 
Physiological role of proctolin-cleaving peptidases 
Our results are consistent with there being extracellularly located 
AP activity within the STG that terminates the neural actions 
of proctolin. This conclusion is based on the fact that the same 
AP inhibitors that effectively suppressed proctolin degradation 
in our biochemical experiments were able to enhance the ex- 
citatory effects of bath-applied proctolin in our electrophysio- 
logical experiments. Although we analyzed the enzymatic deg- 
radation of proctolin using a different ganglion than we used to 
monitor its electrophysiological effects, the order of effectiveness 
of the peptidase inhibitors used in both types of experiments 
was similar. 
In addition to the proctolin-degrading activity reported by us 
to reside within the crab nervous system, there is previously 
1 O’6M Proct.[2-51 
1 Oe5M Proct. 12-51 
5X1 Om5M Proct.[2-51 
10”M Proct. 
‘,“,.r.,,l(.‘.I’, .‘.I.‘.“. 
Is 
Figure II. Effects of Proct. [2-51 on the pyloric motor pattern. Bath 
application of Proct. [2-51 at ~10~~ M to the isolated STG did not 
influence the pyloric motor pattern. However, higher concentrations of 
Proct. [2-5](5 x lo+ M) excited the pyloric motor pattern in a manner 
similar to bath application of proctolin (lo-’ M). Pyloric motor pattern 
was monitored by an extracellular ecording of the dvn. All recordings 
were from the same preparation. 
reported proctolin-degrading activity within the crustacean he- 
molymph. Schwarz et al. (1984) reported that, in preliminary 
experiments where they injected exogenous proctolin in the he- 
molymph of the lobster Homarus americanus, proctolin was 
degraded with a half-life of 6-10 min. Proctolin cleavage also 
occurs in insect hemolymph (Steele and Stat-rat& 1985). Because 
the STG is located within a major artery, any neurally released 
proctolin that was not degraded by ganglionic enzyme activity 
would likely be degraded in the hemolymph. Our experiments 
Table 4. The effect of Proct. [2-51 on the pyloric cycle frequency (Hz) 
Saline (n = 6) 
1O-8 M proctolin (n = 7) 
lo-’ M proct. [2-51 (n = 3) 
lo+ M proct. [2-51 (n = 4) 
1O-s M proct. [2-51 (n = 4) 
5 x lo+ M proct. [2-51 (n = 5) 
lo-’ r+4 proctolin (n = 10) 
Saline super-fusion 
0.49 f  0.04 
0.59 AI 0.2 
0.55 + 0.1 
0.55 + 0.2 
0.47 + 0.2 
0.56 k 0.1 
0.53 zk 0.1 
Incubation 1 Incubation 2 
0.53 + 0.1 
0.58 III 0.1 
0.64 z!z 0.1 
0.61 + 0.2 
0.56 + 0.1 
0.61 f 0.2 
0.61 + 0.2 
0.55 * 0.1t 
0.63 zk O.lt 
0.64 rt O.lt 
0.64 + O.lt 
0.65 xk 0.04 
0.79 f  0.2* 
0.76 f  0.2* 
Details are as for Table 2. 
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Table 5. The effect of Proct. [2-51 on the number of spikes per burst in the LP neuron 
Saline superfusion Incubation 1 Incubation 2 
Saline (n = 6) 4.3 + 1.0 4.4 * 0.7 3.8 k 0.9t 
lo-* M proctolin (n = 7) 4.9 k 1.9 5.1 + 1.7 6.8 + 1.8t 
lo-’ M proct. [2-51 (n = 3) 3.8 + 2.5 3.4 + 2.0 3.2 f  1.1t 
1O-6 M proct. [2-51 (n = 4) 4.3 -t 2.8 4.6 + 2.5 5.2 k 2.8t 
1O-5 M proct. [2-51 (n = 4) 4.6 k 3.9 4.4 * 3.1 7.2 + 3.4-f 
5 x 1O-5 M proct. [2-51 (n = 5) 5.7 +- 2.4 4.5 f  2.3 11.8 zk 1.7* 
lo-’ M proctolin (n = 10) 4.3 k 2.7 4.6 k 2.3 12.9 + 3.2* 
Details are as for Table 2. 
do not enable us to predict which of these two sources of proc- 
tolin-degrading activity would be larger. 
We were surprised to find that proctolin was only approxi- 
mately 500-fold more effective than Proct. [2-51 in exciting the 
pyloric motor pattern. An earlier study by Starratt and Brown 
(1979) using a proctolin-sensitive muscle assay, showed that 
proctolin was > lo6 x more effective than Proct. [2-51. Whether 
this difference results from different proctolin receptors, differ- 
ential sensitivities to resident peptidases, or differential access 
to receptors remains to be determined. 
The proctolin degradation reported in the present study may 
well contribute to the relatively short-lasting excitatory effects 
of two proctolin-containing neurons, MPN and MCNl, on the 
pyloric motor pattern in the crab STG (Nusbaum and Marder, 
1989a,b; Nusbaum et al., 1992; Christie et al., 1993; Coleman 
and Nusbaum, 1994). Whereas some modulatory neurons have 
effects that long outlast their period of impulse activity (Harris- 
Warrick et al., 1992b), the effects of both MPN and MCNl 
subside within seconds after their activity is terminated (Nus- 
baum and Marder, 1989a,b; Nusbaum et al., 1992). Because the 
effects of the proctolin neurons on the pyloric rhythm are equiv- 
alent to bath application of 10m7 M to 1O-6 M proctolin and 
threshold for proctolin actions on this system is approximately 
1O-9 M (Marder et al., 1986; Nusbaum and Marder, 1989b), the 
local concentration of neurally released proctolin probably de- 
creases by 2-3 orders of magnitude within several seconds or 
less. Such a rapid decrease in local proctolin concentration would 
be facilitated by the proctolin-cleaving actions identified in the 
present study. Finally, since many extracellularly located pep- 
tidases cleave more than one neuropeptide (Turner et al., 1985; 
Turner, 1987), it is possible that the peptidase activities docu- 
mented in this study also degrade other neurally released pep- 
tides in the crustacean nervous system. 
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